INNV

Innovus Pharmaceuticals, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 4/11/2017
Contact Info
  • 9171 Towne Centre Drive
  • Suite 440
  • San Diego, CA 92122

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001411879
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. Not Available
Employees 8 a/o May 01, 2015
Company Officers/Contacts
Bassam Damaj, Ph D President, CEO, IR
Robert Hoffman CFO, EVP
Reuven Rubinson VP, Fin.
Randy Berholtz General Counsel
Company Directors
Henry Esber Chairman
Bassam Damaj, Ph D
Vivian Liu
Ziad Mirza
Service Providers
Accounting/Auditing Firm
Hall & Company CPAs & Consultants, Inc.
111 Pacifica
Suite 300
Irvine, CA, 92618
United States
 
Securities Counsel
Weintraub Law Group PC
10085 Carroll Canyon Rd.
Suite 230
San Diego, CA, 92131
United States
 
Investor Relations Firm
Chesapeake Group
305 Washington Ave
Suite 100
Towson, MD, 21204
United States
 
Company History
  • Formerly=North Horizon, Inc. until 12-2011
INNV Security Details
Share Structure
Market Value1 $14,638,631 a/o Sep 22, 2017
Authorized Shares 150,000,000 a/o Sep 30, 2016
Outstanding Shares 151,303,679 a/o Aug 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 15,301,429 a/o Apr 12, 2016
Par Value 0.001
Transfer Agent(s)
Interwest Transfer Co., Inc.
Shareholders
Shareholders of Record 544 a/o Mar 09, 2017
Short Selling Data
Short Interest 134,397 (221.46%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security